Through
4/26
A new study from Penn Medicine shows that LMNA gene mutations can disrupt the ‘identity’ of heart muscle cells, leading to a congenital form of dilated cardiomyopathy.
To start the process of unpacking tightly bundled genetic material, plants depend on the LEAFY pioneer protein, according to work led by biologist Doris Wagner.
Changing conditions have taken a toll on insects in the tropics, according to research by School of Arts & Sciences biologists Daniel Janzen and Winnie Hallwachs. But education and science offer a path forward, they say.
The lab of César de la Fuente is working on a paper-based biosensor that could provide results in minutes. Clinical trials began Jan. 5.
New research from School of Nursing has discovered that certain biological chemicals are expressed on specific cell types and neural circuits in the brain that reduce cocaine-seeking behavior.
Led by School of Arts & Sciences prof Brian Gregory and postdoc Xiang Yu, researchers have uncovered one way plants respond to hormonal cues. A similar process is likely at play in mammals.
New research has discovered a cell type that governs the way bones form and maintain themselves, opening up a potential target for future therapies for bone disorders like osteoporosis.
Qi Long and E. Michael Ostap of the Perelman School of Medicine are among a cohort of 489 distinguished scientists recognized with the honor from the American Association for the Advancement of Science.
Students in introductory biology laboratory courses in the School of Arts & Sciences used customized laboratory kits to get hands-on practice with the scientific method.
The Presidential Professor of cancer biology leads a team that is working to understand how cancer grows uncontrolled in cells and discovering novel ways to stop it.
According to Colleen Tewksbury of the School of Nursing, research suggests that L-theanine may help support stress management, sleep, and potentially weight management.
FULL STORY →
Scott Hensley of the Perelman School of Medicine is working on a flu vaccine to provide protection against 20 subtypes of flu that may pose a pandemic threat in the future.
FULL STORY →
A study by César de la Fuente of the Perelman School of Medicine and colleagues used AI to recreate molecules from ancient humans that could be potential candidates for antimicrobial treatments.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that several current hypotheses for the pathophysiology of long COVID are linked by a single pathway that is connected by serotonin reduction.
FULL STORY →